Lincomycin Hydrochloride Injection

Lincosamide Hydrochloride Injection is used to treat severe infections of the respiratory tract, including pneumonia, lung abscesses, and severe acute bronchitis, especially when caused by Streptococcus species, Staphylococcus aureus, or Anaerobes.

Effective for managing severe skin and soft tissue infections such as cellulitis, abscesses, and wound infections that are not responding to other antibiotics. It is particularly useful for infections caused by methicillin-resistant Staphylococcus aureus (MRSA).

Lincosamide Hydrochloride Injection is indicated for the treatment of osteomyelitis (bone infection) and septic arthritis in patients with Staphylococcal or Streptococcal infections, especially in severe or complicated cases.

This injection is used in the treatment of intra-abdominal infections, such as peritonitis or appendicitis, caused by anaerobic and Gram-positive bacteria. It helps reduce the risk of systemic infection in patients undergoing abdominal surgery or with ruptured organs.

Lincosamide Hydrochloride Injection is employed to manage pelvic inflammatory disease (PID) and other gynecological infections, particularly in patients with bacterial vaginosis or endometritis.

In patients with severe bacteremia or sepsis, particularly from Gram-positive or anaerobic organisms, this injection helps manage infection while ensuring broad-spectrum coverage.

It is used as part of a multi-drug regimen in the treatment of endocarditis (infection of the heart valves) caused by Streptococcus or Staphylococcus species, often when the patient cannot tolerate penicillin or cephalosporins.